Tompkins Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Tompkins Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-500	Closed	-$49.4K	–	600
2024 Q3	$49.4K	Hold	500	–	–	﹤0.01%	339
2024 Q2	$46.4K	Sell	500 -100	-17%	-$8.97K	﹤0.01%	348
2024 Q1	$56.9K	Buy	600 +100	+20%	+$9.28K	0.01%	335
2023 Q4	$44.6K	Hold	500	–	–	0.01%	351
2023 Q3	$36.5K	Sell	500 -200	-29%	-$16K	0.01%	348
2023 Q2	$58.2K	Hold	700	–	–	0.01%	318
2023 Q1	$53.3K	Hold	700	–	–	0.01%	329
2022 Q4	$58K	Buy	700 +100	+17%	+$8.1K	0.01%	320
2022 Q3	$48K	Hold	600	–	–	0.01%	333
2022 Q2	$45K	Hold	600	–	–	0.01%	338
2022 Q1	$54K	Buy	+600	New	+$55.4K	0.01%	343
2019 Q3	–	Sell	-170	Closed	-$15K	–	359
2019 Q2	$15K	Hold	170	–	–	﹤0.01%	313
2019 Q1	$15K	Buy	+170	New	+$14.5K	﹤0.01%	331

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Tompkins Financial's XBI Position: Q4 2024 in Review

Tompkins Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2024, closing a stake of 500 shares — an estimated $49.4K sold.

Tompkins Financial first reported a position in XBI in Q1 2019 and held it in 13 quarters. The position peaked at $58.2K in Q2 2023. 738 funds tracked by Wall St. Rank hold XBI as of Q4 2024.

Tompkins Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2024 after selling out during the quarter.
Tompkins Financial sold 500 State Street SPDR S&P Biotech ETF shares in Q4 2024, an estimated $49.4K.
Tompkins Financial first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 13 quarters.
Tompkins Financial's State Street SPDR S&P Biotech ETF position peaked at $58.2K in Q2 2023.
738 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2024.

Based on Tompkins Financial's 13F filing for Q4 2024, filed 15 Jan 2025.